Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles
Authors:
- F. RothweilerFRF. Rothweiler
- M. MichaelisMMM. Michaelis
- J. CinatlJCJ. Cinatl
- J. KreuterJKJ. Kreuter
- K. LangerKLK. Langer
- 1 August 2007
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 341 (1-2) , 207-214
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivoJournal of Hepatology, 2005
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004
- Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticlesInternational Journal of Cancer, 2004
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- Transferrin Conjugates of Doxorubicin: Synthesis, Characterization, Cellular Uptake, and in Vitro Efficacy||Journal of Pharmaceutical Sciences, 1998
- Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking processInternational Journal of Pharmaceutics, 1997
- HPLC methods for the determination of bound and free doxorubicin, and of bound and free galactosamine, in methacrylamide polymer-drug conjugatesJournal of Pharmaceutical and Biomedical Analysis, 1996
- Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patientsJACC, 1993
- Aphidicolin selectively kills neuroblastoma cells in vitroCancer Letters, 1992
- Safety and efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical resultsJACC, 1990